These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15551196)

  • 41. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex.
    Simbrey K; Winterhoff H; Butterweck V
    Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.
    Watkins RE; Maglich JM; Moore LB; Wisely GB; Noble SM; Davis-Searles PR; Lambert MH; Kliewer SA; Redinbo MR
    Biochemistry; 2003 Feb; 42(6):1430-8. PubMed ID: 12578355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. St John's wort, a herbal antidepressant, activates the steroid X receptor.
    Wentworth JM; Agostini M; Love J; Schwabe JW; Chatterjee VK
    J Endocrinol; 2000 Sep; 166(3):R11-6. PubMed ID: 10974665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
    Moore LB; Goodwin B; Jones SA; Wisely GB; Serabjit-Singh CJ; Willson TM; Collins JL; Kliewer SA
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7500-2. PubMed ID: 10852961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.
    Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF
    Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
    Nahrstedt A; Butterweck V
    J Nat Prod; 2010 May; 73(5):1015-21. PubMed ID: 20408551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
    Kraus B; Wolff H; Elstner EF; Heilmann J
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):541-53. PubMed ID: 20369228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
    Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
    FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of St. John's wort on free radical production.
    Hunt EJ; Lester CE; Lester EA; Tackett RL
    Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.
    Cantoni L; Rozio M; Mangolini A; Hauri L; Caccia S
    Toxicol Sci; 2003 Sep; 75(1):25-30. PubMed ID: 12857935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. St John's wort: Prozac from the plant kingdom.
    Di Carlo G; Borrelli F; Ernst E; Izzo AA
    Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
    Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J
    Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperforin: more than an antidepressant bioactive compound?
    Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
    Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
    Martínez-Poveda B; Quesada AR; Medina MA
    Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M; Singer A; Siebert B; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.
    Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W
    Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.